Improvement in naltrexone treatment compliance with contingency management

Kenzie L. Preston; Kenneth Silverman; Annie Umbricht; Anna Dejesus; Ivan D. Montoya; Charles R. Schuster

doi:10.1016/S0376-8716(98)00152-5

Improvement in naltrexone treatment compliance with contingency management

Kenzie L. Preston, Kenneth Silverman, Annie Umbricht, Anna Dejesus, Ivan D. Montoya, Charles R. Schuster

Research output: Contribution to journal › Article › peer-review

128 Scopus citations

Abstract

The efficacy of a voucher-based incentive program for improving adherence to outpatient, thrice weekly naltrexone maintenance was tested in a three group, randomized, 12-week clinical trial. Voucher incentives were given as follows: contingent group (n=19) for each consecutive naltrexone dose ingested; non-contingent group (n=19) on unpredictable schedule independently of taking naltrexone; no-voucher group (n=20) none. Vouchers were exchangeable for goods and services. The contingent group had significantly longer treatment retention and ingested significantly more doses of naltrexone (consecutive and total) than either control group. Voucher incentives can significantly increase adherence to naltrexone maintenance in recently detoxified opioid dependent individuals. Copyright (C) 1999 Elsevier Science Ireland Ltd.

Original language	English (US)
Pages (from-to)	127-135
Number of pages	9
Journal	Drug and alcohol dependence
Volume	54
Issue number	2
DOIs	https://doi.org/10.1016/S0376-8716(98)00152-5
State	Published - Apr 1 1999
Externally published	Yes

Keywords

Contingency management
Naltrexone
Opioid-dependence
Treatment
Treatment compliance

ASJC Scopus subject areas

Toxicology
Pharmacology
Psychiatry and Mental health
Pharmacology (medical)

Access to Document

10.1016/S0376-8716(98)00152-5

Cite this

@article{91a4f88ffefe4f7b9a8f4bc0b04b57f5,

title = "Improvement in naltrexone treatment compliance with contingency management",

abstract = "The efficacy of a voucher-based incentive program for improving adherence to outpatient, thrice weekly naltrexone maintenance was tested in a three group, randomized, 12-week clinical trial. Voucher incentives were given as follows: contingent group (n=19) for each consecutive naltrexone dose ingested; non-contingent group (n=19) on unpredictable schedule independently of taking naltrexone; no-voucher group (n=20) none. Vouchers were exchangeable for goods and services. The contingent group had significantly longer treatment retention and ingested significantly more doses of naltrexone (consecutive and total) than either control group. Voucher incentives can significantly increase adherence to naltrexone maintenance in recently detoxified opioid dependent individuals. Copyright (C) 1999 Elsevier Science Ireland Ltd.",

keywords = "Contingency management, Naltrexone, Opioid-dependence, Treatment, Treatment compliance",

author = "Preston, {Kenzie L.} and Kenneth Silverman and Annie Umbricht and Anna Dejesus and Montoya, {Ivan D.} and Schuster, {Charles R.}",

note = "Funding Information: This research was supported by the Intramural Research Program of the National Institute on Drug Abuse. The authors thank Marcia Hoffman, the Archway treatment and technical staff, and the NIDA IRP nursing staff for their contribution toward conducting this study.",

year = "1999",

month = apr,

day = "1",

doi = "10.1016/S0376-8716(98)00152-5",

language = "English (US)",

volume = "54",

pages = "127--135",

journal = "Drug and alcohol dependence",

issn = "0376-8716",

publisher = "Elsevier Ireland Ltd",

number = "2",

}

TY - JOUR

T1 - Improvement in naltrexone treatment compliance with contingency management

AU - Preston, Kenzie L.

AU - Silverman, Kenneth

AU - Umbricht, Annie

AU - Dejesus, Anna

AU - Montoya, Ivan D.

AU - Schuster, Charles R.

N1 - Funding Information: This research was supported by the Intramural Research Program of the National Institute on Drug Abuse. The authors thank Marcia Hoffman, the Archway treatment and technical staff, and the NIDA IRP nursing staff for their contribution toward conducting this study.

PY - 1999/4/1

Y1 - 1999/4/1

N2 - The efficacy of a voucher-based incentive program for improving adherence to outpatient, thrice weekly naltrexone maintenance was tested in a three group, randomized, 12-week clinical trial. Voucher incentives were given as follows: contingent group (n=19) for each consecutive naltrexone dose ingested; non-contingent group (n=19) on unpredictable schedule independently of taking naltrexone; no-voucher group (n=20) none. Vouchers were exchangeable for goods and services. The contingent group had significantly longer treatment retention and ingested significantly more doses of naltrexone (consecutive and total) than either control group. Voucher incentives can significantly increase adherence to naltrexone maintenance in recently detoxified opioid dependent individuals. Copyright (C) 1999 Elsevier Science Ireland Ltd.

AB - The efficacy of a voucher-based incentive program for improving adherence to outpatient, thrice weekly naltrexone maintenance was tested in a three group, randomized, 12-week clinical trial. Voucher incentives were given as follows: contingent group (n=19) for each consecutive naltrexone dose ingested; non-contingent group (n=19) on unpredictable schedule independently of taking naltrexone; no-voucher group (n=20) none. Vouchers were exchangeable for goods and services. The contingent group had significantly longer treatment retention and ingested significantly more doses of naltrexone (consecutive and total) than either control group. Voucher incentives can significantly increase adherence to naltrexone maintenance in recently detoxified opioid dependent individuals. Copyright (C) 1999 Elsevier Science Ireland Ltd.

KW - Contingency management

KW - Naltrexone

KW - Opioid-dependence

KW - Treatment

KW - Treatment compliance

UR - http://www.scopus.com/inward/record.url?scp=0032965664&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032965664&partnerID=8YFLogxK

U2 - 10.1016/S0376-8716(98)00152-5

DO - 10.1016/S0376-8716(98)00152-5

M3 - Article

C2 - 10217552

AN - SCOPUS:0032965664

SN - 0376-8716

VL - 54

SP - 127

EP - 135

JO - Drug and alcohol dependence

JF - Drug and alcohol dependence

IS - 2

ER -

Improvement in naltrexone treatment compliance with contingency management

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this